In prostate cancer, BRCA1/2 mutations represent around 13% of the of DDR genes alterations in tumor samples and 51% of all germline variants found in individuals affected by prostate cancer, with BRCA2 harboring the majority of variants [46]. Here, BRCA1 is linked to prostate carcinoma.